|
|
|
|
Endovascular Approach Takes Lead Over Surgery for AAA Repair
Increase in EVAR driving increased AAA repair in elderly EVAR has fewer complications, especially in oldest patients Endovascular repair for abdominal aortic aneurysms (AAAs) is rapidly outstripping the conventional open surgical...
|
|
|
Augmentation Index Relates to Progression of Aortic Disease in Adults With Marfan Syndrome
1Centre of Cardiology and Cardiovascular Surgery, University Hospital Eppendorf, Hamburg, Germany 2Department of Cardiology, Medical Clinic and Policlinic, University of Wurzburg, Wurzburg, Germany 3Department of Diagnostic and...
|
|
|
High lipoprotein (a) linked to presence of abdominal aortic aneurysm
MedWire News: Results from a meta-analysis suggest that individuals with abdominal aortic aneurysm have higher levels of lipoprotein (Lp)(a) than controls.Increased circulating Lp(a) concentrations are predictive for several forms...
|
|
|
Endologix Added to Russell Indexes
IRVINE, Calif., June 30 /PRNewswire-FirstCall/ -- Endologix, Inc., developer of minimally invasive treatments for aortic disorders, today announced that it has been added to the Russell 3000(R), Russell 2000(R) and Russell Global...
|
|
|
SYNTAX makes interventionists and surgeons come together
ESC Communications: In which hospital are you working and what is your current role with the ESC?David Taggart: I am a Professor of Cardiovascular Surgery, at the University of Oxford, Consultant Cardiac Surgeon, at John Radcliffe...
|
|
|
Swiss biotech business Symetis raises 15m in venture funding
Lausanne-based biotechnology company Symetis has raised CHF23m (15.1m) in a financing round co-led by Wellington Partners and Vinci CapitalRenaissance.The firms were joined by new investor Banexi Venture Partners and existing backers...
|
|
|
Swiss biotech business Symetis raises 15m in venture funding
Lausanne-based biotechnology company Symetis has raised CHF23m (15.1m) in a financing round co-led by Wellington Partners and Vinci CapitalRenaissance.The firms were joined by new investor Banexi Venture Partners and existing backers...
|
|
|
Swiss biotech business Symetis raises ,15m in venture funding
Lausanne-based biotechnology company Symetis has raised CHF23m (15.1m) in a financing round co-led by Wellington Partners and Vinci CapitalRenaissance.The firms were joined by new investor Banexi Venture Partners and existing backers...
|
|
|
Acute management of aortobronchial and aortoesophageal fistulas using thoracic endovascular aortic repair
Receive free subspecialty '5-minute updates' via email The Journal of Thoracic and Cardiovascular Surgery, 06/03/09 The Journal of Thoracic and Cardiovascular S Acute management of aortobronchial and aortoesophageal fistulas using thoracic...
|
|
|
Endovascular repair of mycotic aortic aneurysms
Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3.Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. Endovascular...
|
|
|
Cardiovascular involvement in primary systemic vasculitis
(Click the title below to leave the MDLinx Network and go to the Journal's Website) Best Practice & Research: Clinical Rheumatology, 07/01/09 Print Save in My Library Free Abstract Mukhtyar C et al.A review summarizes data...
|
|
|
An atypical 7q11.23 deletion in a normal IQ WilliamsBeuren syndrome patient
WilliamsBeuren syndrome (WBS; OMIM no.194050) is a multisystemic neurodevelopmental disorder caused by a hemizygous deletion of 1.55 Mb on chromosome 7q11.23 spanning 28 genes. Haploinsufficiency of the ELN gene was shown to be...
|
|
|
PCT to offer private CVD tests alongside vascular checks
UniMedic, a private provider of cardiovascular screening, says it will pilot use of its tests for arterial stiffness in NHS Ealing, and is hopeful of striking deals with another five to 10 trusts across the country.Delegates at the...
|
|
|
Endologix Added to Russell Indexes
IRVINE, Calif., June 30 /PRNewswire-FirstCall/ -- Endologix, Inc., developer of minimally invasive treatments for aortic disorders, today announced that it has been added to the Russell 3000(R), Russell 2000(R) and Russell Global...
|
|
|
Reducing Gaseous Microemboli May Protect Brain During CABG
A device designed to reduce gaseous microemboli during coronary artery bypass grafting (CABG) appears to offer some protection from post-procedural neuropsychological damage.In a study published online June 18, 2009, ahead of print in the...
|
|
|
Outcomes and Safety of Percutaneous Aortic Valve Replacement
_ Outcomes and Safety of Percutaneous Aortic Valve Replacement.
|
|
|
Four Out Of 106 Heart Replacement Valves From Pig Hearts Failed
Pig heart valves used to replace defective aortic valves in human patients failed much earlier and more often than expected, says a report from cardiac surgeons at Washington University School of Medicine in St.Louis. This is the...
|
|
|
Four Out of 106 Heart Replacement Valves from Pig Hearts Failed
Newswise Pig heart valves used to replace defective aortic valves in human patients failed much earlier and more often than expected, says a report from cardiac surgeons at Washington University School of Medicine in St.Louis.
|
|
|
Cadmium is a novel and independent risk factor for early atherosclerosis mechanisms and in vivo relevance
Cd independently associated with early atherosclerotic vessel wall thickening (intima-media thickness >90th percentile of distribution In line, Cd-fed ApoE knockout mice yielded a significantly increased aortic plaque surface vs...
|
|
|
Screening Prevents Aneurysm Deaths, But Questions Remain Over Cost Effectiveness
The national aortic screening programme in the UK should, in due course, prevent about half of all aneurysm deaths in men over 65 and will be extremely cost effective for the NHS, conclude researchers in a study published on.However...
|
|
|
BioGlue(R) Surgical Adhesive Hits 500,000 Procedure Milestone Worldwide, Company Data Indicates
'I have been using BioGlue since its market introduction almost 10 years ago,' said Dr.John W. Fehrenbacher A two-component adhesive, BioGlue creates a flexible, mechanical seal, independent of the body's clotting mechanism. BioGlue...
|
|
|
BioGlue(R) Surgical Adhesive Hits 500,000 Procedure Milestone Worldwide, Company Data Indicates
ATLANTA 'I have been using BioGlue since its market introduction almost 10 years ago,' said Dr.John W. Fehrenbacher, Methodist Hospital, Indianapolis, Ind. A two-component adhesive, BioGlue creates a flexible, mechanical seal,...
|
|
|
Four out of 106 heart replacement valves from pig hearts failed
-- Pig heart valves used to replace defective aortic valves in human patients failed much earlier and more often than expected, says a report from cardiac surgeons at Washington University in St.Louis. This is the first report to...
|
|
|
4 out of 106 heart replacement valves from pig hearts failed
Pig heart valves used to replace defective aortic valves in human patients failed much earlier and more often than expected, says a report from cardiac surgeons at in St.Louis. This is the first report to demonstrate this...
|
|
|
BioGlue(R) Surgical Adhesive Hits 500,000 Procedure Milestone Worldwide, Company Data Indicates
ATLANTA, June 29 /PRNewswire-FirstCall/ -- CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, today announced that, according to company data, CryoLife's BioGlue(R) Surgical Adhesive has...
|
